Blood samplesfrom patients with CRC stages III–IV showed reduced ADK-LmRNA levels (p  < 0.001) as compared to healthydonors (Fig. 1).Meanwhile, no significant differences wereobserved in ADK-L mRNA levels between patients at early stages(I–II) and the control group. This evidence concerns the gene ADK and colorectal carcinoma.